Antibodies to hepatitis C virus (anti-HCV): prevalence in the same geographical area in dialysis patients, staff members, and blood donors.
We studied the anti-HCV prevalence in the same period in all the dialysis patients, staff members and blood donors of the same geographical area. In our opinion, the low prevalence (10.26%) in dialysis patients is strictly correlated to the low prevalence (0.46%) in blood donors.
Malaguti
M
M
Nephrology Center, Ospedale San Paolo, Civitavecchia, Italy.
Capece
R
R
Marciano
M
M
Arena
G
G
Luciani
M P
MP
Striano
M
M
Biagini
M
M
D000328:Adult; D000368:Aged; D000369:Aged, 80 and over; D001782:Blood Donors; D005260:Female; D006436:Hemodialysis Units, Hospital; D016174:Hepacivirus / Q000276:immunology*; D006508:Hepatitis Antibodies / Q000097:blood*; D006526:Hepatitis C / Q000453:epidemiology* / Q000276:immunology / Q000635:transmission; D006801:Humans; D007558:Italy / Q000453:epidemiology; D008297:Male; D008875:Middle Aged; D010564:Personnel, Hospital; D006435:Renal Dialysis / Q000009:adverse effects; D016036:Seroepidemiologic Studies
D006508:Hepatitis Antibodies